CREDIT SUISSE AG/ - BIOSCRIP INC ownership

BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 103 filers reported holding BIOSCRIP INC in Q4 2017. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of BIOSCRIP INC
ValueSharesWeighting
Q2 2019$56,000
-5.1%
21,482
-27.3%
0.00%
Q1 2019$59,000
-27.2%
29,550
+30.7%
0.00%
Q4 2018$81,000
-19.0%
22,602
-33.9%
0.00%
Q2 2018$100,000
-6.5%
34,219
-20.9%
0.00%
Q1 2018$107,000
-13.7%
43,271
+1.6%
0.00%
Q4 2017$124,000
-42.9%
42,571
-46.0%
0.00%
Q3 2017$217,000
+167.9%
78,821
+164.8%
0.00%
Q2 2017$81,000
+145.5%
29,771
+54.8%
0.00%
Q1 2017$33,000
-34.0%
19,233
-60.7%
0.00%
Q4 2016$50,000
-79.3%
48,879
-41.4%
0.00%
Q3 2016$241,000
+65.1%
83,409
+45.4%
0.00%
Q2 2016$146,000
-22.3%
57,378
-46.6%
0.00%
Q4 2015$188,000
-65.1%
107,452
-62.7%
0.00%
-100.0%
Q3 2015$538,000
+20.4%
287,977
+133.8%
0.00%
Q2 2015$447,000
+46.6%
123,174
+79.7%
0.00%
Q1 2015$305,000
-72.9%
68,546
-57.5%
0.00%
-100.0%
Q4 2014$1,127,000
-12.6%
161,141
-13.7%
0.00%0.0%
Q3 2014$1,290,000
-32.6%
186,635
-18.7%
0.00%
-50.0%
Q2 2014$1,913,000
+72.8%
229,507
+44.8%
0.00%
+100.0%
Q1 2014$1,107,000
-68.7%
158,494
-66.8%
0.00%
-66.7%
Q4 2013$3,534,000
+34.7%
477,557
+59.8%
0.00%0.0%
Q3 2013$2,623,000
+27.5%
298,791
+139.5%
0.00%
+50.0%
Q2 2013$2,058,000
+147.4%
124,759
+90.5%
0.00%
+100.0%
Q1 2013$832,00065,4750.00%
Other shareholders
BIOSCRIP INC shareholders Q4 2017
NameSharesValueWeighting ↓
Venor Capital Management LP 11,933,605$23,867,00030.16%
Alta Fundamental Advisers LLC 2,723,753$5,448,0003.66%
Coliseum Capital Management, LLC 1,888,991$3,778,0001.36%
ARES MANAGEMENT LLC 7,188,615$14,377,0000.89%
Mesirow Financial Investment Management, Inc. 105,362$211,0000.84%
ROANOKE ASSET MANAGEMENT CORP/ NY 463,780$928,0000.43%
PERKINS CAPITAL MANAGEMENT INC 231,000$462,0000.30%
GILDER GAGNON HOWE & CO LLC 13,611,958$27,224,0000.29%
Millrace Asset Group, Inc. 153,671$307,0000.26%
PERRITT CAPITAL MANAGEMENT INC 269,957$540,0000.20%
View complete list of BIOSCRIP INC shareholders